CDH2 and cervical carcinoma: As shown in Figure 2a and 2b, the forced over-expression of miR-375 induced EMT process in cervical cancer cells, characterized by acquisition of fibroblast-like cell morphology, suppression of Ecadherin expression (65%∼69.2%), and enhancement of vimentin, Ncadherin, and fibronectin expression, similar to the effects observed in the paclitaxel treated cells.